Recursion Pharmaceuticals
(NASDAQ) RXRX
Recursion Pharmaceuticals Financials at a Glance
Market Cap
$1.77B
Revenue (TTM)
$66.29M
Net Income (TTM)
-$559.78M
EPS (TTM)
-$1.20
P/E Ratio
-2.78
Dividend
$0.00
Beta (Volatility)
2.37 (High)
Dividend
$0.00
Beta (Volatility)
2.37 (High)
Price
$3.52
Volume
42,587,971.213
Open
$3.29
Price
$3.52
Volume
42,587,971.213
Open
$3.29
Previous Close
$3.52
Daily Range
$3.28 - $3.62
52-Week Range
$2.77 - $7.18
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
2.37 (High)
Price
$3.52
Volume
42,587,971.213
Open
$3.29
Previous Close
$3.52
Daily Range
$3.28 - $3.62
52-Week Range
$2.77 - $7.18
Estimated Earnings Date
Aug 4, 2026
RXRX News
RXRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Recursion Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
600
CEO
Najat Khan, PhD
Website
www.recursion.comHeadquarters
Salt Lake City, UT 84101, US
RXRX Financials
Key Financial Metrics (TTM)
Gross Margin
-34.44%
Operating Margin
-882.92%
Net Income Margin
-844.46%
Return on Equity
-54.32%
Return on Capital
-53.62%
Return on Assets
-41.79%
Earnings Yield
-35.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.77B
Shares Outstanding
530.76M
Volume
42.59M
Avg. Volume
15.81M
Financials (TTM)
Gross Profit
-$22.83M
Operating Income
-$585.27M
EBITDA
-$479.48M
Operating Cash Flow
-$320.95M
Capital Expenditure
-$4.90M
Free Cash Flow
-$325.85M
Cash & ST Invst.
$654.47M
Total Debt
$72.38M
Recursion Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.47M
-56.1%
Gross Profit
-$6.02M
+15.0%
Gross Margin
-92.99%
N/A
Market Cap
$1.77B
N/A
Market Cap/Employee
$2.22M
N/A
Employees
800
N/A
Net Income
-$117.50M
+42.0%
EBITDA
-$102.09M
+44.2%
Quarterly Fundamentals
Total Cash
$654.47M
+30.8%
Total Debt
$72.38M
-22.1%
Accounts Receivable
$13.59M
-70.5%
Inventory
$0.00
N/A
Long Term Debt
$50.02M
-31.0%
Short Term Debt
$22.35M
+9.4%
Return on Assets
-41.79%
N/A
Return on Invested Capital
-48.38%
N/A
Free Cash Flow
-$81.36M
+39.2%
Operating Cash Flow
-$81.10M
+38.5%